Beta-Blockers Versus Flecainide for Atrial Fibrillation: A First-Line Strategy Review of Efficacy, Safety, and Patient Selection

Cardiology in Review · Published 2026-07-06 · DOI 10.1097/crd.0000000000001396

Free full text

Authors (1)

May Thu Kyaw

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Kyaw, M. (2026). Beta-Blockers Versus Flecainide for Atrial Fibrillation: A First-Line Strategy Review of Efficacy, Safety, and Patient Selection. Cardiology in Review. https://doi.org/10.1097/crd.0000000000001396

Related articles